Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 82249-702

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 82249-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civicascript Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dalfampridine (Dalfampridine Con 1)

Dalfampridine (Dalfampridine Con 1)
This text contains information about a medication with NDC 82249702.60. Each tablet contains 10 mg of Dalfampridine. The dosage instructions are not directly readable. It advises not to divide, crush, chew, or dissolve the tablets. The storage advice is to store at 25°C with excursions permitted. The medication is in extended-release tablet form. It should be dispensed in containers with child-resistant closures, and the label must be kept out of reach of children. The medication is distributed by CreaSoma Laboratories. It recommends pharmacists to dispense with an accompanying Medication Guide to each patient. The total quantity is 60 tablets. Additional information is available online at CiicaScript.com or by scanning the QR code.*
FDA Label Image

Dalfampridine-equa (Dalfampridine Equa)

Dalfampridine-equa (Dalfampridine Equa)
This text contains mathematical equations used to calculate certain parameters related to health assessments. The first equation calculates a value related to age and weight, while the second equation involves the measurement of Serum Creatinine. "Crcl=" may refer to an abbreviation for a parameter or formula related to the calculation of Creatinine clearance, a measure of kidney function.*
FDA Label Image

Dalfampridine-fig1 (Dalfampridine Fig1)

Dalfampridine-fig1 (Dalfampridine Fig1)
FDA Label Image

Dalfampridine-fig2 (Dalfampridine Fig2)

Dalfampridine-fig2 (Dalfampridine Fig2)
This description is not available.*
FDA Label Image

Dalfampridine-struc (Dalfampridine Struc)

Dalfampridine-struc (Dalfampridine Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.